2014
DOI: 10.1016/j.ejmech.2014.03.075
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of 1-aryloxyethyl piperazine derivatives as Kv1.5 potassium channel inhibitors (part I)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 29 publications
0
11
0
1
Order By: Relevance
“…Over the last years, sST2 has been considered as a very promising biomarker to diagnose or monitor patients with One-vessel disease, n (%) 57 (21) Two-vessel disease, n (%) 37 (14) Three-vessel disease, n (%) 52 (19) Myocardial infarction, n (%) 28 (10) Atrial fibrillation, n (%) 26 (9) Stroke, n (%) 10 (4) Peripheral artery disease, n (%) 77 (28) COPD, n (%) 64 (23) Transfemoral access, n (%) 212 (77) heart failure and was investigated as a biomarker in many large clinical trials, mainly in heart failure patients, but also in patients with myocardial infarction [26,28,29]. Moreover, sST2 Figure 1 After 1 year, patients with a sST2 concentration above the optimal cut-off of 10 070Á27 pg/mL evidenced a significantly worse outcome (49Á2% vs. 23Á2%; OR 3Á21 95% CI (1Á70-6Á04); P < 0Á001).…”
Section: Discussionmentioning
confidence: 99%
“…Over the last years, sST2 has been considered as a very promising biomarker to diagnose or monitor patients with One-vessel disease, n (%) 57 (21) Two-vessel disease, n (%) 37 (14) Three-vessel disease, n (%) 52 (19) Myocardial infarction, n (%) 28 (10) Atrial fibrillation, n (%) 26 (9) Stroke, n (%) 10 (4) Peripheral artery disease, n (%) 77 (28) COPD, n (%) 64 (23) Transfemoral access, n (%) 212 (77) heart failure and was investigated as a biomarker in many large clinical trials, mainly in heart failure patients, but also in patients with myocardial infarction [26,28,29]. Moreover, sST2 Figure 1 After 1 year, patients with a sST2 concentration above the optimal cut-off of 10 070Á27 pg/mL evidenced a significantly worse outcome (49Á2% vs. 23Á2%; OR 3Á21 95% CI (1Á70-6Á04); P < 0Á001).…”
Section: Discussionmentioning
confidence: 99%
“…In the latter,t he inclusion of dispersion correction lowers the relative energy of the folded conformationb ut the repulsion between the phenyl groups still plays the dominant role. As imilar free-molecule structure for the same compound was already found by calculations and fluorescenced ip infrared spectroscopy (FDIR) by Buchanan et al [24] Synthesis For ap reparative access to the model compounds, we used a modified protocol by Guo et al [25] Scheme 2d isplays an exemplary route to the asymmetric compound 1-(pentafluorophenoxy)-2-(phenoxy)ethane (2).…”
Section: Resultsmentioning
confidence: 74%
“…For the synthesis of the probe 2 , the fluorescein moiety 3 was treated with 1,2‐dibromo ethane in the presence of excess K 2 CO 3 at 60 °C to give compound 8 . The compound 8 was next subjected to nucleophilic substitution by NaN 3 to yield the corresponding bis ‐azido derivative 9 in 96 % crude yield.…”
Section: Methodsmentioning
confidence: 99%